These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25162040)

  • 1. From sprouting angiogenesis to erythrocytes generation by cancer stem cells: evolving concepts in tumor microcirculation.
    Alameddine RS; Hamieh L; Shamseddine A
    Biomed Res Int; 2014; 2014():986768. PubMed ID: 25162040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
    Sun B; Zhang D; Zhao N; Zhao X
    Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cancer stem cells to modulate alternative vascularization mechanisms.
    Monzani E; La Porta CA
    Stem Cell Rev; 2008; 4(1):51-6. PubMed ID: 18286393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes that regulate metastasis and angiogenesis.
    Webb CP; Vande Woude GF
    J Neurooncol; 2000; 50(1-2):71-87. PubMed ID: 11245283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenesis therapy might have the unintended effect of promoting tumor metastasis by increasing an alternative circulatory system.
    Qu B; Guo L; Ma J; Lv Y
    Med Hypotheses; 2010 Feb; 74(2):360-1. PubMed ID: 19744799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosslink between p53 and metastasis: focus on epithelial-mesenchymal transition, cancer stem cell, angiogenesis, autophagy, and anoikis.
    Babaei G; Aliarab A; Asghari Vostakolaei M; Hotelchi M; Neisari R; Gholizadeh-Ghaleh Aziz S; Bazl MR
    Mol Biol Rep; 2021 Nov; 48(11):7545-7557. PubMed ID: 34519942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor and its microenvironment: a synergistic interplay.
    Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
    Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z
    Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research progress in vasculogenic mimicry in 
multiple tumors].
    Bai J; Xu Z; Liao C; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):357-364. PubMed ID: 28364113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor angiogenesis and anti-angiogenic therapies.
    Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
    Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-Inducible Factors: Master Regulators of Cancer Progression.
    Schito L; Semenza GL
    Trends Cancer; 2016 Dec; 2(12):758-770. PubMed ID: 28741521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of cancer stem cells to tumor vasculogenic mimicry.
    Yao XH; Ping YF; Bian XW
    Protein Cell; 2011 Apr; 2(4):266-72. PubMed ID: 21533771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
    Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
    Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells and their vascular niche: Do they benefit from each other?
    Ping YF; Zhang X; Bian XW
    Cancer Lett; 2016 Oct; 380(2):561-567. PubMed ID: 25979233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.
    Zhang S; Chitu V; Stanley ER; Elliott BE; Greer PA
    Cancer Res; 2011 Feb; 71(4):1465-73. PubMed ID: 21159660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem-like tumor cells involved in heterogeneous vasculogenesis in breast cancer.
    Mao Y; Zhu L; Huang Z; Luo C; Zhou T; Li L; Wang G; Yang Z; Qi W; Yang X; Gao G
    Endocr Relat Cancer; 2020 Jan; 27(1):23-39. PubMed ID: 31705798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
    Donnem T; Hu J; Ferguson M; Adighibe O; Snell C; Harris AL; Gatter KC; Pezzella F
    Cancer Med; 2013 Aug; 2(4):427-36. PubMed ID: 24156015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of erythroid cells from polyploid giant cancer cells: re-thinking about tumor blood supply.
    Yang Z; Yao H; Fei F; Li Y; Qu J; Li C; Zhang S
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):617-627. PubMed ID: 29417259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.